20
Chengdu Shengnuo Biopharm Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is LIRAGLUTIDE, with a corresponding US DMF Number 29302.
Remarkably, this DMF maintains an Active status since its submission on October 07, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 26, 2016, and payment made on September 29, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II